{"id":5441,"date":"2018-09-20T12:45:36","date_gmt":"2018-09-20T10:45:36","guid":{"rendered":"http:\/\/www.rapharm.eu\/hr\/?p=5441"},"modified":"2018-09-20T12:45:36","modified_gmt":"2018-09-20T10:45:36","slug":"uticaj-novih-eu-propisa-na-obaveze-i-odgovornosti-distributera-medicinskih-proizvoda-sredstava","status":"publish","type":"post","link":"https:\/\/www.rapharm.eu\/hr\/uticaj-novih-eu-propisa-na-obaveze-i-odgovornosti-distributera-medicinskih-proizvoda-sredstava\/","title":{"rendered":"Regulatorni seminar i radionica: UTICAJ NOVIH EU PROPISA NA OBAVEZE I ODGOVORNOSTI DISTRIBUTERA MEDICINSKIH PROIZVODA\/SREDSTAVA"},"content":{"rendered":"<style type=\"text\/css\"><\/style><p><strong>29. i 30. novembar\/studeni 2018<\/strong><br \/>\n<strong>Radon Plaza Hotel\u00a0Sarajevo, BIH (hrvatsko-srpsko-bosansko-crnogorski jezik)<\/strong><\/p>\n<p><strong>Regulatorni seminar i radionica<br \/>\nUTICAJ NOVIH EU PROPISA NA OBAVEZE I ODGOVORNOSTI DISTRIBUTERA MEDICINSKIH PROIZVODA\/SREDSTAVA<br \/>\n<\/strong><\/p>\n<p>Nove EU uredbe o mediciniskim proizvodima\/sredstvima \u0107e uticati na ekonomske operatere koji posluju u EU ali i na njihove partnere izvan EU, ne samo zbog harmonizacije propisa nego i zbog sve ve\u0107e usmjerenosti EU proizvo\u0111a\u010da na poslovanje sa uvoznicima i distributerima izvan EU koji dosti\u017eu iste standarde usluga i me\u0111usobnih odnosa kao u EU. Zato je va\u017eno pravilno razumjeti nove zahtijeve i njihov potencijalni uticaj na poslovanje, te sprije\u010diti neprijatna iznena\u0111enja u praksi. Posebno treba ista\u0107i osjetljivo podru\u010dje novih odgovornosti distributera u odnosu na druge partnere. EU distributeri ozbiljno prihvataju savjet da dobro pregledaju postoje\u0107e ugovore u svjetlu novih zahtjeva. Na\u0107i slabe ta\u010dke \u010desto zna\u010di zaobi\u0107i egzistencijalne probleme.<\/p>\n<p><strong>Kliknite\u00a0<a href=\"http:\/\/www.rapharm.eu\/wp-content\/uploads\/2018\/09\/SeminarRadionicaDistributeri2930112018.pdf\" target=\"_blank\">OVDJE<\/a>\u00a0za\u00a0vi\u0161e informacija o seminaru i radionici.<\/strong><\/p>\n<p><strong>Kliknite\u00a0<a href=\"http:\/\/www.rapharm.eu\/hr\/prijavnica-za-obrazovanje\/\" target=\"_blank\">OVDJE<\/a>\u00a0za prijavu na seminar i\u00a0radionicu.<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>29. i 30. novembar\/studeni 2018 Radon Plaza Hotel\u00a0Sarajevo, BIH (hrvatsko-srpsko-bosansko-crnogorski jezik) Regulatorni seminar i radionica UTICAJ NOVIH EU PROPISA NA OBAVEZE I ODGOVORNOSTI DISTRIBUTERA MEDICINSKIH PROIZVODA\/SREDSTAVA Nove EU uredbe o mediciniskim proizvodima\/sredstvima \u0107e uticati na ekonomske operatere koji posluju u EU ali i na njihove partnere izvan EU, ne samo zbog harmonizacije propisa nego i&#8230;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[43,41,31],"tags":[],"class_list":["post-5441","post","type-post","status-publish","format-standard","hentry","category-aktivno-obrazovanje","category-regulatorne-vijesti","category-uncategorized-hr"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Regulatorni seminar i radionica: UTICAJ NOVIH EU PROPISA NA OBAVEZE I ODGOVORNOSTI DISTRIBUTERA MEDICINSKIH PROIZVODA\/SREDSTAVA - raPHARM<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rapharm.eu\/vpliv-nove-evropske-zakonodaje-na-obveznosti-in-odgovornosti-distributerjev-medicinskih-pripomockov\/\" \/>\n<meta property=\"og:locale\" content=\"hr_HR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Regulatorni seminar i radionica: UTICAJ NOVIH EU PROPISA NA OBAVEZE I ODGOVORNOSTI DISTRIBUTERA MEDICINSKIH PROIZVODA\/SREDSTAVA - raPHARM\" \/>\n<meta property=\"og:description\" content=\"29. i 30. novembar\/studeni 2018 Radon Plaza Hotel\u00a0Sarajevo, BIH (hrvatsko-srpsko-bosansko-crnogorski jezik) Regulatorni seminar i radionica UTICAJ NOVIH EU PROPISA NA OBAVEZE I ODGOVORNOSTI DISTRIBUTERA MEDICINSKIH PROIZVODA\/SREDSTAVA Nove EU uredbe o mediciniskim proizvodima\/sredstvima \u0107e uticati na ekonomske operatere koji posluju u EU ali i na njihove partnere izvan EU, ne samo zbog harmonizacije propisa nego i...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rapharm.eu\/vpliv-nove-evropske-zakonodaje-na-obveznosti-in-odgovornosti-distributerjev-medicinskih-pripomockov\/\" \/>\n<meta property=\"og:site_name\" content=\"raPHARM\" \/>\n<meta property=\"article:published_time\" content=\"2018-09-20T10:45:36+00:00\" \/>\n<meta name=\"author\" content=\"rapharm\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"rapharm\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.rapharm.eu\/vpliv-nove-evropske-zakonodaje-na-obveznosti-in-odgovornosti-distributerjev-medicinskih-pripomockov\/\",\"url\":\"https:\/\/www.rapharm.eu\/vpliv-nove-evropske-zakonodaje-na-obveznosti-in-odgovornosti-distributerjev-medicinskih-pripomockov\/\",\"name\":\"Regulatorni seminar i radionica: UTICAJ NOVIH EU PROPISA NA OBAVEZE I ODGOVORNOSTI DISTRIBUTERA MEDICINSKIH PROIZVODA\/SREDSTAVA - raPHARM\",\"isPartOf\":{\"@id\":\"https:\/\/www.rapharm.eu\/#website\"},\"datePublished\":\"2018-09-20T10:45:36+00:00\",\"author\":{\"@id\":\"https:\/\/www.rapharm.eu\/#\/schema\/person\/ba2051c1c51d2328945ac838b3f1d7e1\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.rapharm.eu\/vpliv-nove-evropske-zakonodaje-na-obveznosti-in-odgovornosti-distributerjev-medicinskih-pripomockov\/#breadcrumb\"},\"inLanguage\":\"hr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.rapharm.eu\/vpliv-nove-evropske-zakonodaje-na-obveznosti-in-odgovornosti-distributerjev-medicinskih-pripomockov\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.rapharm.eu\/vpliv-nove-evropske-zakonodaje-na-obveznosti-in-odgovornosti-distributerjev-medicinskih-pripomockov\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.rapharm.eu\/hr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Regulatorni seminar i radionica: UTICAJ NOVIH EU PROPISA NA OBAVEZE I ODGOVORNOSTI DISTRIBUTERA MEDICINSKIH PROIZVODA\/SREDSTAVA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.rapharm.eu\/#website\",\"url\":\"https:\/\/www.rapharm.eu\/\",\"name\":\"raPHARM\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.rapharm.eu\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"hr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.rapharm.eu\/#\/schema\/person\/ba2051c1c51d2328945ac838b3f1d7e1\",\"name\":\"rapharm\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"hr\",\"@id\":\"https:\/\/www.rapharm.eu\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9ea8e299db6979b3c68307fd37c34f245020d4996bcf2ccdeec4bce3350fcc24?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9ea8e299db6979b3c68307fd37c34f245020d4996bcf2ccdeec4bce3350fcc24?s=96&d=mm&r=g\",\"caption\":\"rapharm\"},\"url\":\"https:\/\/www.rapharm.eu\/hr\/author\/rapharm\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Regulatorni seminar i radionica: UTICAJ NOVIH EU PROPISA NA OBAVEZE I ODGOVORNOSTI DISTRIBUTERA MEDICINSKIH PROIZVODA\/SREDSTAVA - raPHARM","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rapharm.eu\/vpliv-nove-evropske-zakonodaje-na-obveznosti-in-odgovornosti-distributerjev-medicinskih-pripomockov\/","og_locale":"hr_HR","og_type":"article","og_title":"Regulatorni seminar i radionica: UTICAJ NOVIH EU PROPISA NA OBAVEZE I ODGOVORNOSTI DISTRIBUTERA MEDICINSKIH PROIZVODA\/SREDSTAVA - raPHARM","og_description":"29. i 30. novembar\/studeni 2018 Radon Plaza Hotel\u00a0Sarajevo, BIH (hrvatsko-srpsko-bosansko-crnogorski jezik) Regulatorni seminar i radionica UTICAJ NOVIH EU PROPISA NA OBAVEZE I ODGOVORNOSTI DISTRIBUTERA MEDICINSKIH PROIZVODA\/SREDSTAVA Nove EU uredbe o mediciniskim proizvodima\/sredstvima \u0107e uticati na ekonomske operatere koji posluju u EU ali i na njihove partnere izvan EU, ne samo zbog harmonizacije propisa nego i...","og_url":"https:\/\/www.rapharm.eu\/vpliv-nove-evropske-zakonodaje-na-obveznosti-in-odgovornosti-distributerjev-medicinskih-pripomockov\/","og_site_name":"raPHARM","article_published_time":"2018-09-20T10:45:36+00:00","author":"rapharm","twitter_card":"summary_large_image","twitter_misc":{"Written by":"rapharm","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.rapharm.eu\/vpliv-nove-evropske-zakonodaje-na-obveznosti-in-odgovornosti-distributerjev-medicinskih-pripomockov\/","url":"https:\/\/www.rapharm.eu\/vpliv-nove-evropske-zakonodaje-na-obveznosti-in-odgovornosti-distributerjev-medicinskih-pripomockov\/","name":"Regulatorni seminar i radionica: UTICAJ NOVIH EU PROPISA NA OBAVEZE I ODGOVORNOSTI DISTRIBUTERA MEDICINSKIH PROIZVODA\/SREDSTAVA - raPHARM","isPartOf":{"@id":"https:\/\/www.rapharm.eu\/#website"},"datePublished":"2018-09-20T10:45:36+00:00","author":{"@id":"https:\/\/www.rapharm.eu\/#\/schema\/person\/ba2051c1c51d2328945ac838b3f1d7e1"},"breadcrumb":{"@id":"https:\/\/www.rapharm.eu\/vpliv-nove-evropske-zakonodaje-na-obveznosti-in-odgovornosti-distributerjev-medicinskih-pripomockov\/#breadcrumb"},"inLanguage":"hr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rapharm.eu\/vpliv-nove-evropske-zakonodaje-na-obveznosti-in-odgovornosti-distributerjev-medicinskih-pripomockov\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.rapharm.eu\/vpliv-nove-evropske-zakonodaje-na-obveznosti-in-odgovornosti-distributerjev-medicinskih-pripomockov\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.rapharm.eu\/hr\/"},{"@type":"ListItem","position":2,"name":"Regulatorni seminar i radionica: UTICAJ NOVIH EU PROPISA NA OBAVEZE I ODGOVORNOSTI DISTRIBUTERA MEDICINSKIH PROIZVODA\/SREDSTAVA"}]},{"@type":"WebSite","@id":"https:\/\/www.rapharm.eu\/#website","url":"https:\/\/www.rapharm.eu\/","name":"raPHARM","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rapharm.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"hr"},{"@type":"Person","@id":"https:\/\/www.rapharm.eu\/#\/schema\/person\/ba2051c1c51d2328945ac838b3f1d7e1","name":"rapharm","image":{"@type":"ImageObject","inLanguage":"hr","@id":"https:\/\/www.rapharm.eu\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9ea8e299db6979b3c68307fd37c34f245020d4996bcf2ccdeec4bce3350fcc24?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9ea8e299db6979b3c68307fd37c34f245020d4996bcf2ccdeec4bce3350fcc24?s=96&d=mm&r=g","caption":"rapharm"},"url":"https:\/\/www.rapharm.eu\/hr\/author\/rapharm\/"}]}},"_links":{"self":[{"href":"https:\/\/www.rapharm.eu\/hr\/wp-json\/wp\/v2\/posts\/5441","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rapharm.eu\/hr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rapharm.eu\/hr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rapharm.eu\/hr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rapharm.eu\/hr\/wp-json\/wp\/v2\/comments?post=5441"}],"version-history":[{"count":2,"href":"https:\/\/www.rapharm.eu\/hr\/wp-json\/wp\/v2\/posts\/5441\/revisions"}],"predecessor-version":[{"id":5443,"href":"https:\/\/www.rapharm.eu\/hr\/wp-json\/wp\/v2\/posts\/5441\/revisions\/5443"}],"wp:attachment":[{"href":"https:\/\/www.rapharm.eu\/hr\/wp-json\/wp\/v2\/media?parent=5441"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rapharm.eu\/hr\/wp-json\/wp\/v2\/categories?post=5441"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rapharm.eu\/hr\/wp-json\/wp\/v2\/tags?post=5441"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}